198 related articles for article (PubMed ID: 28880552)
1. Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo.
Ni S; Wei H; Li B; Chen F; Liu Y; Chen W; Xu Y; Qiu X; Li X; Lu Y; Liu W; Hu L; Lin D; Wang M; Zheng X; Mao F; Zhu J; Lan L; Li J
J Med Chem; 2017 Oct; 60(19):8145-8159. PubMed ID: 28880552
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections.
Wei H; Mao F; Ni S; Chen F; Li B; Qiu X; Hu L; Wang M; Zheng X; Zhu J; Lan L; Li J
Eur J Med Chem; 2018 Feb; 145():235-251. PubMed ID: 29328999
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent Benzocycloalkane Derived Diapophytoene Desaturase Inhibitors with an Enhanced Safety Profile for the Treatment of MRSA, VISA, and LRSA Infections.
Li B; Ni S; Chen F; Mao F; Wei H; Liu Y; Zhu J; Lan L; Li J
ACS Infect Dis; 2018 Mar; 4(3):208-217. PubMed ID: 29377669
[TBL] [Abstract][Full Text] [Related]
4. Detection of high levels of resistance to linezolid and vancomycin in Staphylococcus aureus.
Azhar A; Rasool S; Haque A; Shan S; Saeed M; Ehsan B; Haque A
J Med Microbiol; 2017 Sep; 66(9):1328-1331. PubMed ID: 28857738
[TBL] [Abstract][Full Text] [Related]
5. In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus.
García AB; Candel FJ; López L; Chiarella F; Viñuela-Prieto JM
J Med Microbiol; 2016 Oct; 65(10):1119-1122. PubMed ID: 27553740
[TBL] [Abstract][Full Text] [Related]
6. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).
Kaleem F; Usman J; Khalid A; Hassan A; Omair M
J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972
[TBL] [Abstract][Full Text] [Related]
8. TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.
Kaul M; Mark L; Zhang Y; Parhi AK; Lyu YL; Pawlak J; Saravolatz S; Saravolatz LD; Weinstein MP; LaVoie EJ; Pilch DS
Antimicrob Agents Chemother; 2015 Aug; 59(8):4845-55. PubMed ID: 26033735
[TBL] [Abstract][Full Text] [Related]
9. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
11. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Rio-Marques L; Hartke A; Bizzini A
Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140
[TBL] [Abstract][Full Text] [Related]
12. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
13. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F;
Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147
[TBL] [Abstract][Full Text] [Related]
15. Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
Eissa IH; Mohammad H; Qassem OA; Younis W; Abdelghany TM; Elshafeey A; Abd Rabo Moustafa MM; Seleem MN; Mayhoub AS
Eur J Med Chem; 2017 Apr; 130():73-85. PubMed ID: 28249208
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
Gomes DM; Ward KE; LaPlante KL
Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
[TBL] [Abstract][Full Text] [Related]
17. Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus.
Kaul M; Mark L; Parhi AK; LaVoie EJ; Pilch DS
Antimicrob Agents Chemother; 2016 Jul; 60(7):4290-6. PubMed ID: 27161635
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections.
Wang Y; Chen F; Di H; Xu Y; Xiao Q; Wang X; Wei H; Lu Y; Zhang L; Zhu J; Sheng C; Lan L; Li J
J Med Chem; 2016 Apr; 59(7):3215-30. PubMed ID: 26999509
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Pelitli TS; Cesur S; Kınıklı S; Irmak H; Demiröz AP; Karakoç E
Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]